Sandbox Reserved 1125: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Laura Dutto (talk | contribs) No edit summary |
No edit summary |
||
| Line 85: | Line 85: | ||
Numerous range of compounds such as hydroxamate, thiol, pyrimidine and phosphorus based-molecules were developped. Those inhibitors inhibit the activity of MMPs by chelating the catalytic zinc like <scene name='71/719866/N-hydroxyurea/2'>N-hydroxyurea</scene> for MMP-8. | Numerous range of compounds such as hydroxamate, thiol, pyrimidine and phosphorus based-molecules were developped. Those inhibitors inhibit the activity of MMPs by chelating the catalytic zinc like <scene name='71/719866/N-hydroxyurea/2'>N-hydroxyurea</scene> for MMP-8. | ||
Recently, new range of inhibitors which do not chelate the catalytic zinc were developped. Those compounds target the selectivity regions for substrates of the MMPs rather than binding to the catalytic zinc. For instance, they can interact with the S1' pocket and induce a conformational change like <scene name='71/719866/Non-chelating_inhibitor/ | Recently, new range of inhibitors which do not chelate the catalytic zinc were developped. Those compounds target the selectivity regions for substrates of the MMPs rather than binding to the catalytic zinc. For instance, they can interact with the S1' pocket and induce a conformational change like <scene name='71/719866/Non-chelating_inhibitor/2'>new inhibitors</scene> of MMP-8. | ||
